Feb 14 (Reuters)-
Cosmo Bio Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2017 Dec 31, 2016 Dec 31, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 7.07 7.43 7.50 3.90
(-4.8 pct) (+1.0 pct) (+6.1 pct) (+5.4 pct)
Operating 193 mln 514 mln 195 mln 155 mln
(-62.5 pct) (+156.3 pct) (+1.0 pct) (-24.9 pct)
Recurring 397 mln 483 mln 245 mln 200 mln
(-17.8 pct) (+29.5 pct) (-38.4 pct) (-50.0 pct)
Net
Net 237 mln 254 mln 150 mln 125 mln
(-6.5 pct) (+10.4 pct) (-37.0 pct) (-52.8 pct)
EPS 40.15 yen 42.93 yen 25.30 yen 21.09 yen
Ann Div 14.00 yen 18.00 yen 14.00 yen
-Q2 Div 6.00 yen 6.00 yen 6.00 yen
-Q4 Div 8.00 yen 12.00 yen 8.00 yen
NOTE - Cosmo Bio Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3386.T
((Tokyo Headline News Desk +813 6441 1812))